Document Actions

You are here: Home › Faculty › Professors › Rieg

Rieg

Prof. Dr.
Siegbert Rieg

Department of Medicine II
Phone: 0049-761-27018190

www.uniklinik-freiburg.de/infektiologie

CV

  • 1994-2001 Medical School Eberhard-Karls-University Tübingen and Brown University, Rhode Island, USA
  • 2002-2006 Residency in Dermatology and Venereology, Department of Dermatology, University Hospital, Tübingen
  • 2006-2012 Residency in Internal Medicine and Fellowship in Infectious Diseases, Department of Internal
    Medicine II, Medical Center – University of Freiburg
  • 2014 Habilitation an der Albert-Ludwigs-Universität Freiburg
  • Since 2023 Full Professor and Head of Division of Infectious Diseases, Department of Internal Medicine II, Medical Center – University of Freiburg

Focus of research

  • Host-Pathogen interaction and management of Staphylococcus aureus bloodstream infection and endocarditis
  • Sexually-transmitted and vector-borne infections, Refugee health, Climate change & infectious diseases
  • Implementation research in Infectious Diseases and Antimicrobial Stewardship (AMS)

Selected publications

  • Mathé P, Göpel S, Hornuss D, Tobys D, Käding N, Eisenbeis S, Kohlmorgen B, Trauth J, Gölz H, Walker SV, Mischnik A, Peter S, Hölzl F, Rohde AM, Behnke M, Fritzenwanker M, Häcker G, Steffens B, Vehreschild M, Kramme E, Falgenhauer J, Peyerl-Hoffmann G, Seifert H, Rupp J, Gastmeier P, Imirzalioglu C, Tacconelli E, Kern W, Rieg S; Increasing numbers and complexity of Staphylococcus aureus bloodstream infection-14 years of prospective evaluation at a German tertiary care centre with multi-centre validation of findings;
    DZIF R-Net Study Group. Clin Microbiol Infect. 2023 Jun 3:S1198-743X(23)00255-0.
  • Müller MC, Usadel S, Zimmermann S, Fahrhöfer A, Kern WV, Hoffmeister U, Rieg S.
    Closing Sexual Health Service Gaps With a New Service Model in Germany: Performance of an on-Site Integrated, Cross-Sectoral, Low Threshold Sexually Transmitted Infections/HIV Counseling and Treatment Service
    Front Public Health. 2022 Apr 25;10:793609
  • Camp J, Glaubitz L, Filla T, Kaasch AJ, Fuchs F, Scarborough M, Kim HB, Tilley R, Liao CH, Edgeworth J, Nsutebu E, López-Cortés LE, Morata L, Llewelyn M, Fowler VG, Thwaites G, Seifert H, Kern WV, Kuss O, Rieg S.; Impact of Immunosuppressive Agents on Clinical Manifestations and Outcome of Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Analysis in 2 Large, Prospectively Evaluated Cohorts;
    Clin Infect Dis. 2021 Oct 5;73(7):1239-1247
  • Rieg S, von Cube M, Kalbhenn J, Utzolino S, Pernice K, Bechet L, Baur J, Lang CN, Wagner D, Wolkewitz M, Kern WV, Biever P; COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany;
    COVID UKF Study Group. PLoS One. 2020 Nov 12;15(11):e0242127
  • Rieg S, von Cube M, Kaasch AJ, Bonaventura B, Bothe W, Wolkewitz M, Peyerl-Hoffmann G, Deppe AC, Wahlers T, Beyersdorf F, Seifert H, Kern W; Investigating the Impact of Early Valve Surgery on Survival in Staphylococcus aureus Infective Endocarditis Using a Marginal Structural Model Approach: Results of a Large, Prospectively Evaluated Cohort;
    Clin Infect Dis. 2019 Jul 18;69(3):487-494.

Research methods

  • Cohort studies and registries incl. application of innovative statistical models
  • Transsectoral research
  • Digital PCR